Bottom line
SWHFX vs GGHCX: the short answer
SWHFX (Schwab Health Care Fund) and GGHCX (INVESCO Health Care Fund) share a meaningful slice of their top holdings — about 51% by weight.
SWHFX is cheaper at 0.8% vs 1.07% — a difference of $27 a year per $10,000 invested.
Over five years, SWHFX returned +6.5% a year vs +2.6% for GGHCX.
GGHCX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
SWHFX vs GGHCX side by side
| SWHFX | GGHCX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Schwab | Invesco |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.8% | 1.07% |
| Annual cost per $10k | $80 | $107 |
| 10-yr cost on $10k (prospectus) | $990 | $1,784 |
| Max front load | — | 5.5% |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | +15.9% | +9.2% |
| 5-yr return (annualized) | +6.5% | +2.6% |
| 10-yr return (annualized) | +8.1% | +5.8% |
| Best quarter | +15.3% | +19.6% |
| Worst quarter | −12.1% | −16.5% |
| Net assets (fund) | $642.3M | $1.2B |
| Number of holdings | 80 | 82 |
| Portfolio turnover | 41% | 59% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SWHFX | GGHCX | Difference |
|---|---|---|---|
| 2025 | +15.9% | +15.5% | +0.4% |
| 2024 | +0.1% | +4.0% | −3.9% |
| 2023 | +0.7% | +3.1% | −2.4% |
| 2022 | −4.7% | −13.5% | +8.9% |
| 2021 | +23.3% | +12.2% | +11.1% |
| 2020 | +12.9% | +14.5% | −1.6% |
| 2019 | +17.6% | +32.0% | −14.4% |
| 2018 | +4.0% | +0.5% | +3.5% |
| 2017 | +20.2% | +15.5% | +4.7% |
| 2016 | −4.4% | −11.7% | +7.4% |
Source: Fund prospectus bar charts
Holdings overlap
8 of SWHFX's top 25 holdings also appear in GGHCX's top 25.
| Holding | SWHFX | GGHCX |
|---|---|---|
| Eli Lilly & Co | 13.92% | 10.59% |
| Johnson & Johnson | 6.94% | 6.76% |
| AbbVie Inc | 5.81% | 4.03% |
| Merck & Co Inc | 4.98% | 4.59% |
| UnitedHealth Group Inc | 4.74% | 6.17% |
| Gilead Sciences Inc | 3.24% | 3.63% |
| Thermo Fisher Scientific Inc | 2.16% | 1.55% |
| Vertex Pharmaceuticals Inc | 1.89% | 2.01% |
Source: SEC Form N-PORT
SWHFX top 10
- Eli Lilly & Co — 13.92%
- Johnson & Johnson — 6.94%
- AbbVie Inc — 5.81%
- Merck & Co Inc — 4.98%
- UnitedHealth Group Inc — 4.74%
- Gilead Sciences Inc — 3.24%
- Novartis AG — 2.92%
- Amgen Inc — 2.58%
- Bristol-Myers Squibb Co — 2.44%
- Medtronic PLC — 2.29%
GGHCX top 10
- Eli Lilly and Co. — 10.59%
- Johnson & Johnson — 6.76%
- UnitedHealth Group Inc. — 6.17%
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- AbbVie Inc. — 4.03%
- Gilead Sciences, Inc. — 3.63%
- argenx SE — 3.24%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
FAQ
What is the difference between SWHFX and GGHCX?
Which is cheaper, SWHFX or GGHCX?
Should I own both SWHFX and GGHCX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.